Pharmaceutical Supply Chain Resilience: Navigating Challenges Ahead
Pharmaceutical Supply Chain Resilience in 2025
Pharmaceutical supply chain resilience is a pressing concern in today's shifting market. Industry-wide anxiety about growth and pricing pressures has created a self-fulfilling prophecy in which companies react cautiously, leading to slower growth. Mike Stenberg, vice president at LGM Pharma, explains the industry's transition towards comprehensive supply chain audits to safeguard against disruptions and ensure stability.
Trends Impacting Pharma Supply Chains
- Growing Concerns: A pervasive fear exists about supply chain reliability, which affects overall industry growth.
- Strategic Sourcing: Companies are increasingly diversifying their suppliers and sourcing strategies to include second and third suppliers.
- Geographical Diversification: Efforts are underway to move supply chains away from traditional hubs, although challenges remain in sourcing from the US and Europe due to limited supplies and high costs.
Looking Ahead
As the pharmaceutical industry grapples with these challenges, understanding and enhancing supply chain resilience will be crucial for future growth.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.